A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

NCT00558675 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematological Malignancy
Leukemia
Lymphoma
Multiple Myeloma

Interventions

BIOLOGICAL: AlloStim
BIOLOGICAL: AlloStim
BIOLOGICAL: AlloStim
BIOLOGICAL: AlloStim

Sponsor

Mirror Biologics, Inc.

Collaborators

[object Object]